Artículos -

Navegar

Últimos Documentos Autor FCEN - Año Autor FCEN - Revista Año - Revista Revista - Año SubjectPcEn Colores Type

Colección

Lista de

$
0
1
-
1
1
-
1
-
1
-
1
1
1
2
3
4
5
6
7
8
9
a
a
-
a
-
a
-
a
-
a
-
a
-
a
-
a
-
a
-
a
-
a
-
‐
a
-
‐
-
a
-
a
-
a
-
a
-
a
-
a
-
‐
a
-
a
-
a
-
a
b
-
b
-
b
-
b
c
-
c
-
c
-
c
-
c
-
c
-
c
-
c
-
c
+
c
-
c
-
c
-
c
-
c
-
c
-
c
-
c
c
-
c
-
c
d
-
d
-
d
-
d
-
d
-
d
-
d
e
-
e
-
e
-
e
-
e
-
e
-
e
-
e
-
e
f
-
f
-
f
f
g
-
g
-
g
-
g
-
g
-
g
-
g
-
g
-
‐
g
-
g
-
‐
g
-
g
h
‐
h
h
-
h
-
h
-
h
-
h
i
-
i
j
k
-
k
-
k
-
k
-
k
-
k
l
-
l
-
l
-
l
-
l
-
l
-
l
l
+
l
±
l
l
m
-
m
-
m
-
m
-
m
-
m
+
m
-
m
-
m
-
m
-
‐
m
n
-
n
-
n
-
n
-
n
o
p
-
p
p
-
p
-
p
q
r
-
r
-
r
s
-
s
-
s
{
s
-
s
t
-
t
‐
-
t
-
t
-
t
t
-
t
u
v
v
w
x
-
x
y
z
α
β
—
,
δ
π
-

carcinogenesis

"Inhibition of Notch signaling attenuates pituitary adenoma growth in Nude mice" (2019) Zubeldía-Brenner, L.;De Winne, C.;Perrone, S. (...)Becu-Villalobos, D. Endocrine-Related Cancer. 26(1):13-29

"Targeting galectin-1 inhibits pancreatic cancer progression by modulating tumor–stroma crosstalk" (2018) Orozco, C.A.;Martinez-Bosch, N.;Guerrero, P.E. (...)Navarro, P. Proceedings of the National Academy of Sciences of the United States of America. 115(16):E3769-E3778

"Stable and high expression of Galectin-8 tightly controls metastatic progression of prostate cancer" (2017) Gentilini, L.D.;Jaworski, F.M.;Tiraboschi, C. (...)Compagno, D. Oncotarget. 8(27):44654-44668

"Programmed cell senescence: Role of IL-6 in the pituitary" (2017) Sapochnik, M.; Fuertes, M.; Arzt, E. Journal of Molecular Endocrinology. 58(4):R241-R253

"Galectins: emerging regulatory checkpoints linking tumor immunity and angiogenesis" (2017) Méndez-Huergo, S.P.; Blidner, A.G.; Rabinovich, G.A. Current Opinion in Immunology. 45:8-15

"Turning-off signaling by siglecs, selectins, and galectins: Chemical inhibition of glycan-dependent interactions in cancer" (2016) Cagnoni, A.J.; Pérez Sáez, J.M.; Rabinovich, G.A.; Mariño, K.V. Frontiers in Oncology. 6(MAY)

"Biological relevance of Hsp90-binding immunophilins in cancer development and treatment" (2016) Mazaira, G.I.;Camisay, M.F.;De Leo, S. (...)Galigniana, M.D. International Journal of Cancer. 138(4):797-808

"Molecular Mechanisms Underlying Pituitary Pathogenesis" (2016) Sapochnik, M.; Nieto, L.E.; Fuertes, M.; Arzt, E. Biochemical Genetics. 54(2):107-119

"Role of RSUME in inflammation and cancer" (2015) Antico Arciuch, V.G.; Tedesco, L.; Fuertes, M.; Arzt, E. FEBS Letters. 589(22):3330-3335

"Galectins: Major signaling modulators inside and outside the cell" (2014) Compagno, D.;Jaworski, F.M.;Gentilini, L. (...)Laderach, D.J. Current Molecular Medicine. 14(5):630-651

"Linking tumor hypoxia with VEGFR2 signaling and compensatory angiogenesis: Glycans make the difference" (2014) Croci, D.O.; Rabinovich, G.A. OncoImmunology. 3(6)

"Galectin-8: A matricellular lectin with key roles in angiogenesis" (2014) Troncoso, M.F.;Ferragut, F.;Bacigalupo, M.L. (...)Elola, M.T. Glycobiology. 24(10):907-914

"P19INK4d is involved in the cellular senescence mechanism contributing to heterochromatin formation" (2014) Sonzogni, S.V.;Ogara, M.F.;Belluscio, L.M. (...)Cánepa, E.T. Biochimica et Biophysica Acta - General Subjects. 1840(7):2171-2183

"Folding of a cyclin box: Linking multitarget binding to marginal stability, oligomerization, and aggregation of the retinoblastoma tumor suppressor ab pocket domain" (2013) Chemes, L.B.; Noval, M.G.; Sánchez, I.E.; De Prat-Gay, G. Journal of Biological Chemistry. 288(26):18923-18938

"Metronidazole induced DNA damage in somatic cells of Drosophila melanogaster" (2013) Palermo, A.M.; Mudry, M.D. Current Drug Safety. 8(3):195-198

"When the cell stress society international became South American: Meeting report of the IX international workshop on the molecular biology of stress responses" (2013) Galigniana, M.D. Cell Stress and Chaperones. 18(1):3-9

"Coupling between transcription and alternative splicing" (2013) Schor, I.E.; Gómez Acuña, L.I.; Kornblihtt, A.R.; Wu J.Y. Cancer Treatment and Research:1-24

"Tumor-specific MAGE proteins as regulators of p53 function" (2012) Ladelfa, M.F.;Peche, L.Y.;Toledo, M.F. (...)Monte, M. Cancer Letters. 325(1):11-17

"Advanced prostate cancer: Reinforcing the strings between inflammation and the metastatic behavior" (2012) Gueron, G.; De Siervi, A.; Vazquez, E. Prostate Cancer and Prostatic Diseases. 15(3):213-221

"Disrupting galectin-1 interactions with N-glycans suppresses hypoxia-driven angiogenesis and tumorigenesis in Kaposi's sarcoma" (2012) Croci, D.O.;Salatino, M.;Rubinstein, N. (...)Rabinovich, G.A. Journal of Experimental Medicine. 209(11):1985-2000

"Animal models for aberrations of gonadotropin action" (2011) Peltoketo, H.; Zhang, F.-P.; Rulli, S.B. Reviews in Endocrine and Metabolic Disorders. 12(4):245-258

"Pituitary tumors: Cell type-specific roles for BMP-4" (2010) Labeur, M.;Páez-Pereda, M.;Haedo, M. (...)Stalla, G.K. Molecular and Cellular Endocrinology. 326(1-2):85-88

"Cytokines and genes in pituitary tumorigenesis: RSUME role in cell biology" (2010) Fuertes, M.;Gerez, J.;Haedo, M. (...)Arzt, E. Frontiers of Hormone Research. 38:1-6

"VEGF and CD31 association in pituitary adenomas" (2010) Cristina, C.;Perez-Millan, M.I.;Luque, G. (...)Becu-Villalobos, D. Endocrine Pathology. 21(3):154-160

"Emerging roles of ATF2 and the dynamic AP1 network in cancer" (2010) Lopez-Bergami, P.; Lau, E.; Ronai, Z. Nature Reviews Cancer. 10(1):65-76

"c-Jun regulates phosphoinositide-dependent kinase 1 transcription: Implication for Akt and protein kinase C activities melanoma tumorigenesis" (2010) Lopez-Bergami, P.;Kim, H.;Dewing, A. (...)Ronai, Z. Journal of Biological Chemistry. 285(2):903-913

"Differential gene expression in models of pituitary prolactin-producing tumoral cells" (2009) Giacomini, D.;Haedo, M.;Gerez, J. (...)Arzt, E. Hormone Research. 71(SUPPL2):88-94

"High-risk HPV E6 oncoproteins assemble into large oligomers that allow localization of endogenous species in prototypic HPV-transformed cell lines" (2007) García-Alai, M.M.;Dantur, K.I.;Smal, C. (...)De Prat-Gay, G. Biochemistry. 46(2):341-349

"PTTG expression in different experimental and human prolactinomas in relation to dopaminergic control of lactotropes" (2007) Cristina, C.;Díaz-Torga, G.S.;Goya, R.G. (...)Becu-Villalobos, D. Molecular Cancer. 6

"INK4 proteins, a family of mammalian CDK inhibitors with novel biological functions" (2007) Cánepa, E.T.;Scassa, M.E.;Ceruti, J.M. (...)Ogara, M.F. IUBMB Life. 59(7):419-426

"Nuclear translocation of haeme oxygenase-1 is associated to prostate cancer" (2007) Sacca, P.;Meiss, R.;Casas, G. (...)Vazquez, E. British Journal of Cancer. 97(12):1683-1689

"The Gα12/13 family of heterotrimeric G proteins and the small GTPase RhoA link the Kaposi sarcoma-associated herpes virus G protein-coupled receptor to heme oxygenase-1 expression and tumorigenesis" (2007) Martín, M.J.;Tanos, T.;García, A.B. (...)Marinissen, M.J. Journal of Biological Chemistry. 282(47):34510-34524

"Pituitary action of cytokines: Focus on BMP-4 and gp130 family" (2007) Giacomini, D.;Acuña, M.;Gerez, J. (...)Arzt, E. Neuroendocrinology. 85(2):94-100

"Association of estrogen receptor-α and progesterone receptor A expression with hormonal mammary carcinogenesis: Role of the host microenvironment" (2007) Montero Girard, G.;Vanzulli, S.I.;Cerliani, J.P. (...)Lanari, C. Breast Cancer Research. 9(2)

"Inhibition of heme oxygenase-1 interferes with the transforming activity of the Kaposi sarcoma herpesvirus-encoded G protein-coupled receptor" (2006) Marinissen, M.J.;Tanos, T.;Bolós, M. (...)Cuadrado, A. Journal of Biological Chemistry. 281(16):11332-11346

"Multiple sites of tumorigenesis in transgenic mice overproducing hCG" (2005) Huhtaniemi, I.; Rulli, S.; Ahtiainen, P.; Poutanen, M. Molecular and Cellular Endocrinology. 234(1-2):117-126

"Fetal but not adult Leydig cells are susceptible to adenoma formation in response to persistently high hCG level: A study on hCG overexpressing transgenic mice" (2005) Ahtiainen, P.;Rulli, S.B.;Shariatmadari, R. (...)Huhtaniemi, I.T. Oncogene. 24(49):7301-7309

"Involvement of the gp130 cytokine transducer in MtT/S pituitary somatotroph tumour development in an autocrine-paracrine model" (2004) Graciarena, M.;Carbia-Nagashima, A.;Onofri, C. (...)Arzt, E. European Journal of Endocrinology. 151(5):595-604

"Inhibition of in vivo breast cancer growth by antisense oligodeoxynucleptides to type I insulin-like growth factor receptor rnRNA involves inactivation of ErbBs, PI-3K/Akt and p42/p44 MAPK signaling pathways but not modulation of progesterone receptor activity" (2004) Salatino, M.;Schillaci, R.;Proietti, C.J. (...)Elizalde, P.V. Oncogene. 23(30):5161-5174

"Integrating systemic information at the molecular level: Cross-talk between steroid receptors and cytokine signaling on different target cells" (2003) Refojo, D.;Liberman, A.C.;Giacomini, D. (...)Arzt, E. Annals of the New York Academy of Sciences. 992:196-204

"Heregulin induces transcriptional activation of the progesterone receptor by a mechanism that requires functional ErbB-2 and mitogen-activated protein kinase activation in breast cancer cells" (2003) Labriola, L.;Salatino, M.;Proietti, C.J. (...)Elizalde, P.V. Molecular and Cellular Biology. 23(3):1095-1111

"Reduced expression of the cytokine transducer gp130 inhibits hormone secretion, cell growth, and tumor development of pituitary lactosomatotrophic GH3 cells" (2003) Perez Castro, C.;Giacomini, D.;Carbia Nagashima, A. (...)Arzt, E. Endocrinology. 144(2):693-700

"Sexual dimorphism in diethylstilbestrol-induced prolactin pituitary tumors in F344 rats" (2000) Piroli, G.G.;Torres, A.;Pietranera, L. (...)De Nicola, A.F. Neuroendocrinology. 72(2):80-90

"Mitochondrial and cytosolic rhodanese from liver of DAB-treated mice III. Inhibition kinetic studies" (1997) Vazquez, E.; Gazzaniga, S.; Polo, C.; Batlle, A. Cancer Biochemistry Biophysics. 15(4):285-293

"Effects of sarcoma 180 growth on interleukin-1 and circulating immune complexes" (1994) Chasseing, N.A.; Eugui, E.M.; Borda, E.S.; Rumi, L. Cancer Investigation. 12(4):390-394

"Porphyrins, porphyrias, cancer and photodynamic therapy - a model for carcinogenesis" (1993) Del Batlle, C.A.M. Journal of Photochemistry and Photobiology, B: Biology. 20(1):5-22